Generation Bio Co expected to post a loss of 58 cents a share - Earnings Preview

Generation Bio

20/02/2023 11:01

* Generation Bio Co  GBIO.OQ   GBIO.O  is expected to show
no
change in quarterly revenue when it reports  results on February
22 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Generation Bio Co
is for
a loss of 58 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Generation
Bio Co
is $16​, above​ its last closing price of $4.78. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.66       -0.67      -0.53     Beat    21.1
 Jun. 30 2022  -0.63       -0.62      -0.66     Missed  -6
 Mar. 31 2022  -0.53       -0.52      -0.61     Missed  -16.2​
 Dec. 31 2021  -0.58       -0.57      -0.54     Beat    5.3
 ​​Sep.        -0.56       -0.56      -0.56     Met     -0.6
 30 2021                                                
 Jun. 30 2021  -0.47       -0.47      -0.55     Missed  -17.7​
 Mar. 31 2021  -0.45       -0.45      -0.46     Missed  -2.2
 Dec. 31 2020  -0.48       -0.50      -0.27     Beat    46.4
 This summary was machine generated February 20 at 11:01 GMT. 
All figures in US dollars  unless otherwise stated